1, Xilong Science Co., Ltd (referred to as "Xilong Science", stock code: 002584), formerly known as Xilong Chemical Co., Ltd, was founded in 1983, listed on the Shenzhen Stock Exchange in June 2011, the first in the domestic chemical reagent industry to land on the capital market, a rapid refreshing development map. Since the listing, the company has transformed from a production-oriented enterprise to a production-service-oriented enterprise; from traditional marketing to Internet marketing; and from endogenous operation to a combination of epitaxial M&A and endogenous development.
2, the company is the national torch plan key high-tech enterprises, participated in drafting and revising a number of national and industry standards, focusing on the development of distillation, electrochemistry and other core high-tech, with a number of professional and advanced precision testing equipment and a number of well-equipped production line workshop, undertake a number of national and provincial scientific research projects. At the same time, the company attaches importance to the discovery and cultivation of technical talents, experienced R & D team, R & D capabilities continue to develop, involved in national and provincial torch program and other science and technology, innovation, technological reform projects 35, with independent intellectual property rights of 24 patents, including 11 patents of invention. The company has set up academician workstation and postdoctoral research station, leading the company's technological development in the direction of internationalization, standardization and high-end development through internal cultivation and external industry-university-research cooperation, hiring external experts and academicians, and introducing overseas high-end scholars.
3, business layout, Xilong Science's current business scope covers chemical reagents, chemical raw materials, diagnostic reagents, gene sequencing services and third-party independent medical laboratories, with more than 1,000 on-the-job employees, six production bases, five logistics and distribution centers, with general chemicals and hazardous chemicals, transportation and storage business qualifications, and with BASF, Procter & Gamble, Solvay, SKC, the Netherlands, AkzoNobel and many other industries. It maintains long-term strategic cooperative relationships with a number of giant enterprises in the industry, such as BASF, P&G, Solvay, SKC, AkzoNobel, and so on.
4, the reagent segment of the company after more than 30 years of development, the formation of general reagents, PCB electronic chemicals, ultra-clean and high-purity solvents, biological reagents, four business segments, and supplemented by APIs, food additives, laboratory products and chemical raw materials for the integration of high-tech product chain and industry group, covering nearly 10,000 product categories and more than 10,000 product specifications. Meanwhile, the company continuously enriches its product lines through self-development and external mergers and acquisitions, and in 2014, the company acquired Shenzhen Huaxun and Hunan Huaxun to rapidly promote the development of electroplating chemicals business. The company's marketing service network covers the domestic and Asia-Pacific regions, with 41 marketing branches and offices***, and has developed into a leading professional manufacturer and integrated supplier of chemical reagents in China in terms of research and development capability, sales coverage, and comprehensive supporting scale.
5, genetic testing as an important technology carrier of the concept of precision medicine, has a good market prospect and development space, is in recent years the in vitro diagnostic industry, one of the fastest growing segments. Since 2014, the company through the holding of new continent biology, holding Yonghe Sunshine, the acquisition of part of the equity of the United States Fulgent company, the formation of a third-party medical laboratory, and BASF signed a strategic cooperation agreement, holding Shandong Acuvue Biotechnology Co., Ltd. and so on, and actively layout of the big health industry chain, genetic testing business thick and thin, into the fast lane development.